SCHEDULE 13D

Company

BioLineRx Ltd.

Filed

August 8, 2017

Accession Number

0000921895-17-002050

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →